Biological meaning of stage and grade in human breast cancer: Review and hypothesis Francis E. Sharkey Review Pages: 299 - 322
Digital dermatoglyphics and breast cancer Murray H. SeltzerChris C. PlatoH. Stephen Fletcher Reports Pages: 261 - 265
Parity and breast cancer: Confirmed evidence of an effect on age at diagnosis Maurizio MacalusoMarcello TamburiniSergio Di Pietro Reports Pages: 257 - 260
Oestrogen and progesterone receptor content and the distribution of histological grade in breast cancer S. ThoresenT. ThorsenF. Hartveit Reports Pages: 251 - 255
Estrogen and progesterone receptors: Correlation of response rates, site and timing of receptor analysis John StewartRoger KingRobert Rubens Reports Pages: 243 - 250
Cellularity and the quantitation of estrogen receptors R. C. MasonR. J. C. SteeleA. P. M. Forrest Reports Pages: 239 - 242
Dolichol-bound oligosaccharides and the transfer of distal monosaccharides in the synthesis of glycoproteins by normal and tumor mammary epithelial cells Armando J. ParodiEdward W. BlankRoberto L. Ceriani Reports Pages: 227 - 237
Prognostic significance of serum IgE levels in primary breast cancer Dennis R. OwnbyHelen E. Ownbythe Breast Cancer Prognostic Study Associates Reports Pages: 221 - 226
The current status of primary radiation therapy in the treatment of early breast cancer Nancy Tarbell LeslieJay R. HarrisSamuel Hellman Review Pages: 213 - 220
Non-contraceptive exogenous estrogens and risk of breast cancer: A review David B. Thomas Review Pages: 203 - 211
Progesterone receptor as a more reliable prognostic parameter than estrogen receptor in patients with advanced breast cancer H. MagdelénatP. PouillartB. Asselain Correspondence Pages: 195 - 195
Variability of steroid receptors in multiple biopsies of breast cancer: Effect of systemic therapy Yeu-Tsu N. (Margaret) Lee Report Pages: 185 - 193
Presurgical radiotherapy decreases the concentrations of estrogen and progesterone receptors in human breast cancer: A 200-patient study N. BressotF. VeithH. Rochefort Report Pages: 177 - 183
Estrogen receptor status as a prognostic indicator for stage I breast cancer patients Joseph P. CroweCharles A. HubayParticipating Investigators Report Pages: 171 - 176
Effect of timing of initiation of adjuvant chemotherapy on disease-free survival in breast cancer Aman U. BuzdarTerry L. SmithEdmund A. Gehan Report Pages: 163 - 169
The contralateral breast at reconstructive surgery after breast cancer operation — A histopathological study Anita RingbergBjörn PalmerFolke Linell Report Pages: 151 - 161
Luteal phase defect and breast cancer genesis Pierre Mauvais-JarvisRégine Sitruk-WareFrédérique Kuttenn Review Pages: 139 - 150
Metabolites of tamoxifen in animals and man: Identification, pharmacology, and significance V. Craig JordanC. Chem. Review Pages: 123 - 138
Quality control for estrogen receptor quantification by dextran-coated charcoal assay: A single laboratory's experience Shanthi RaamRebecca GelmanJoseph L. Cohen Reports Pages: 111 - 117
The axillary nodes and tumor size in breast cancer F. HartveitM. TangenJ. F. Halvorsen Reports Pages: 105 - 109
Bilateral ovariectomy in premenopausal patients with advanced breast cancer, after the evaluation of estrogen receptors and urinary androgen excretion Saro OrianaGiorgio SecretoFerdinando Preda Reports Pages: 101 - 104
A phase II trial of tamoxifen, premarin, methotrexate and 5-fluorouracil in metastatic breast cancer Joseph C. AllegraThomas M. WoodcockJames L. Wittliff Reports Pages: 93 - 99
Autologous bone marrow transplantation in metastatic breast cancer Patricia S. Stewart Fourth Annual San Antonio Breast Cancer Symposium Pages: 85 - 92
Adjuvant therapy of breast cancer 1971–1981 Paul P. Carbone Fourth Annual San Antonio Breast Cancer Symposium Pages: 75 - 84
Differentiation of the mammary gland and susceptibility to carcinogenesis Jose RussoLee K. TayIrma H. Russo Review Pages: 5 - 73
Growth regulation of two rat adenocarcinoma cell lines by dexamethasone and progesterone E. JolyF. VignonH. Rochefort Reports Pages: 381 - 389
Nil-8 conditioned medium stimulates growth of human mammary epithelial cells Ian S. FentimanJacky HurstJoyce Taylor-Papadimitriou Reports Pages: 375 - 379
Total prolactin binding sites in human breast cancer biopsies J. P. PeyratD. DewaillyJ. Lefebvre Reports Pages: 369 - 373
Lack of efficacy of xeromammography in preoperatively detecting lobular carcinoma in situ of the breast Don M. MorrisAlonzo P. WalkerDonald C. Coker Reports Pages: 365 - 368
Effect of chemotherapy on survival in metastatic breast cancer Alexander H. G. PatersonOlga SzafranJohn Hanson Reports Pages: 357 - 363
Adjuvant CMF effect on site of first recurrence, and appropriate follow-up intervals, in operable breast cancer with positive axillary nodes P. ValagussaJ. D. Tesoro TessG. Bonadonna Reports Pages: 349 - 356
Surgery in the primary treatment of breast cancer Norman WolmarkBernard Fisher 4th Annual San Antonio Breast Cancer Symposium Pages: 339 - 348
Cytochemistry of sex steroid receptors: A critique K. S. McCarty JrD. S. ReintgenK. S. McCarty Sr. Viewpoints Pages: 315 - 325
Immunohistologic and histochemical methods for detection of steroid binding in breast cancer: A reappraisal Louis P. PertschukEllis H. TobinNorman D. Bloom Viewpoints Pages: 297 - 314
Corpus luteum dysfunction and the epidemiology of breast cancer: A reconsideration Barry M. ShermanRobert B. WallaceStanley G. Korenman Review Pages: 287 - 296
Glycosylated haemoglobin levels in breast cancer patients receiving cytotoxic chemotherapy B. CantwellI. F. ShirleyJ. J. Fennelly Correspondence Pages: 281 - 282
Repeat screening by single oblique view mammography Bengt LundgrenSören Jakobsson Reports Pages: 273 - 280
Factors affecting dehydroepiandrosterone sulphate levels in human breast secretions W. R. MillerV. HumeniukA. P. M. Forrest Reports Pages: 267 - 272
Tumour steroid hormone synthesis and estrogen receptor status in breast cancer patients R. C. MasonD. A. BurnsA. P. M. Forrest Reports Pages: 263 - 266
